These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


105 related items for PubMed ID: 10674262

  • 21. [Distribution of pathogen and resistance of nosocomial infections in the intensive care units].
    Dai CM, Zhou JD, Wu Y, Qi Y.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):277-80. PubMed ID: 16706133
    [Abstract] [Full Text] [Related]

  • 22. [Surveillance of bacterial resistance in China (1998-1999)].
    Li J, Weinstein AJ, Yang M, China Bacterial Resistance Surveillance Study Group.
    Zhonghua Yi Xue Za Zhi; 2001 Jan 10; 81(1):8-16. PubMed ID: 11798843
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Susceptibility of Pseudomonas aeruginosa to antimicrobials: a 2004 French multicentre hospital study.
    Cavallo JD, Hocquet D, Plesiat P, Fabre R, Roussel-Delvallez M, GERPA (Groupe d'Etude de la Résistance de Pseudomonas aeruginosa aux antibiotiques).
    J Antimicrob Chemother; 2007 May 10; 59(5):1021-4. PubMed ID: 17412726
    [Abstract] [Full Text] [Related]

  • 25. [Estimation of level of aminoglycosides susceptibility of bacterial strains isolated from patients with systemic and general infections].
    Kowalska-Krochmal B, Dolna I, Dobosz A, Wrzyszcz E, Gościniak G.
    Med Dosw Mikrobiol; 2008 May 10; 60(3):205-14. PubMed ID: 19143174
    [Abstract] [Full Text] [Related]

  • 26. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients.
    Adachi JA, Perego C, Graviss L, Dvorak T, Hachem R, Chemaly RF, Raad II.
    Am J Infect Control; 2009 Aug 10; 37(6):442-6. PubMed ID: 19118923
    [Abstract] [Full Text] [Related]

  • 27. Determination of epidemic clonality among multidrug-resistant strains of Acinetobacter spp. and Pseudomonas aeruginosa in the MYSTIC Programme (USA, 1999-2003).
    Jones RN, Deshpande L, Fritsche TR, Sader HS.
    Diagn Microbiol Infect Dis; 2004 Jul 10; 49(3):211-6. PubMed ID: 15246512
    [Abstract] [Full Text] [Related]

  • 28. Device-associated nosocomial infection rates in intensive care units of seven Indian cities. Findings of the International Nosocomial Infection Control Consortium (INICC).
    Mehta A, Rosenthal VD, Mehta Y, Chakravarthy M, Todi SK, Sen N, Sahu S, Gopinath R, Rodrigues C, Kapoor P, Jawali V, Chakraborty P, Raj JP, Bindhani D, Ravindra N, Hegde A, Pawar M, Venkatachalam N, Chatterjee S, Trehan N, Singhal T, Damani N.
    J Hosp Infect; 2007 Oct 10; 67(2):168-74. PubMed ID: 17905477
    [Abstract] [Full Text] [Related]

  • 29. Investigation of beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa isolated from non-tertiary care hospitals in Korea.
    Suk SE, Yoo JS, Lee JK, Lee KM, Chung GT, Shin ES, Han SY, Lee SH, Kim J, Lee YS.
    J Microbiol Biotechnol; 2007 Oct 10; 17(10):1733-7. PubMed ID: 18156795
    [Abstract] [Full Text] [Related]

  • 30. Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010.
    Nordmann P, Naas T, Fortineau N, Poirel L.
    Curr Opin Microbiol; 2007 Oct 10; 10(5):436-40. PubMed ID: 17765004
    [Abstract] [Full Text] [Related]

  • 31. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
    Xiao QZ, Su DH, Jiang JH, Zhong NS.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb 10; 25(2):132-8. PubMed ID: 15698988
    [Abstract] [Full Text] [Related]

  • 32. The time-related changes of antimicrobial resistance patterns and predominant bacterial profiles of burn wounds and body flora of burned patients.
    Altoparlak U, Erol S, Akcay MN, Celebi F, Kadanali A.
    Burns; 2004 Nov 10; 30(7):660-4. PubMed ID: 15475138
    [Abstract] [Full Text] [Related]

  • 33. Contemporary antimicrobial activity of triple antibiotic ointment: a multiphased study of recent clinical isolates in the United States and Australia.
    Jones RN, Li Q, Kohut B, Biedenbach DJ, Bell J, Turnidge JD.
    Diagn Microbiol Infect Dis; 2006 Jan 10; 54(1):63-71. PubMed ID: 16368476
    [Abstract] [Full Text] [Related]

  • 34. Susceptibility of Staphylococcus aureus isolated from skin and wound infections in the United States 2005-07: laboratory-based surveillance study.
    Tillotson GS, Draghi DC, Sahm DF, Tomfohrde KM, Del Fabro T, Critchley IA.
    J Antimicrob Chemother; 2008 Jul 10; 62(1):109-15. PubMed ID: 18397923
    [Abstract] [Full Text] [Related]

  • 35. Prevalence of multidrug-resistant, methicillin-resistant Staphylococcus aureus in the United States: findings of the stratified analysis of the 2004 to 2005 LEADER Surveillance Programs.
    Pillar CM, Draghi DC, Sheehan DJ, Sahm DF.
    Diagn Microbiol Infect Dis; 2008 Feb 10; 60(2):221-4. PubMed ID: 17976944
    [Abstract] [Full Text] [Related]

  • 36. [Drug-resistant bacteria in clinical situations].
    Watanabe A.
    Rinsho Byori; 2000 Jan 10; Suppl 111():9-16. PubMed ID: 10804787
    [Abstract] [Full Text] [Related]

  • 37. The importance of addressing multidrug resistance and not assuming single-drug resistance in case-control studies.
    D'Agata EM, Cataldo MA, Cauda R, Tacconelli E.
    Infect Control Hosp Epidemiol; 2006 Jul 10; 27(7):670-4. PubMed ID: 16807840
    [Abstract] [Full Text] [Related]

  • 38. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S, Warner M, Ge Y, Kaniga K, Livermore DM.
    J Antimicrob Chemother; 2007 Aug 10; 60(2):300-11. PubMed ID: 17548456
    [Abstract] [Full Text] [Related]

  • 39. Information concerning multidrug-resistant bacterial colonization or infection in the medical transfer letter.
    Lefebvre A, Laporte S, Faure S, Tiv M, Chavanet P, Belpois-Duchamp C, Astruc K, Aho-Glélé LS.
    Med Mal Infect; 2015 Jul 10; 45(7):286-92. PubMed ID: 26123765
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of the contribution of isolation precautions in prevention and control of multi-resistant bacteria in a teaching hospital.
    Eveillard M, Eb F, Tramier B, Schmit JL, Lescure FX, Biendo M, Canarelli B, Daoudi F, Laurans G, Rousseau F, Thomas D.
    J Hosp Infect; 2001 Feb 10; 47(2):116-24. PubMed ID: 11170775
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.